Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bryan E. Thacker is active.

Publication


Featured researches published by Bryan E. Thacker.


Nature Medicine | 2011

Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome

Madeline A. Lancaster; Dipika Gopal; Joon Yong Kim; Sahar N. Saleem; Jennifer L. Silhavy; Carrie M. Louie; Bryan E. Thacker; Yuko Williams; Maha S. Zaki; Joseph G. Gleeson

The ciliopathy Joubert syndrome is marked by cerebellar vermis hypoplasia, a phenotype for which the pathogenic mechanism is unclear. To investigate Joubert syndrome pathogenesis, we have examined mice with mutated Ahi1, the first identified Joubert syndrome–associated gene. These mice show cerebellar hypoplasia with a vermis-midline fusion defect early in development. This defect is concomitant with expansion of the roof plate and is also evident in a mouse mutant for another Joubert syndrome–associated gene, Cep290. Furthermore, fetal magnetic resonance imaging (MRI) of human subjects with Joubert syndrome reveals a similar midline cleft, suggesting parallel pathogenic mechanisms. Previous evidence has suggested a role for Jouberin (Jbn), the protein encoded by Ahi1, in canonical Wnt signaling. Consistent with this, we found decreased Wnt reporter activity at the site of hemisphere fusion in the developing cerebellum of Ahi1-mutant mice. This decrease was accompanied by reduced proliferation at the site of fusion. Finally, treatment with lithium, a Wnt pathway agonist, partially rescued this phenotype. Our findings implicate a defect in Wnt signaling in the cerebellar midline phenotype seen in Joubert syndrome that can be overcome with Wnt stimulation.


Matrix Biology | 2014

Heparan sulfate 3-O-sulfation: A rare modification in search of a function☆☆☆

Bryan E. Thacker; Ding Xu; Roger Lawrence; Jeffrey D. Esko

Many protein ligands bind to heparan sulfate, which results in their presentation, protection, oligomerization or conformational activation. Binding depends on the pattern of sulfation and arrangement of uronic acid epimers along the chains. Sulfation at the C3 position of glucosamine is a relatively rare, yet biologically significant modification, initially described as a key determinant for binding and activation of antithrombin and later for infection by type I herpes simplex virus. In mammals, a family of seven heparan sulfate 3-O-sulfotransferases installs sulfate groups at this position and constitutes the largest group of sulfotransferases involved in heparan sulfate formation. However, to date very few proteins or biological systems have been described that are influenced by 3-O-sulfation. This review describes our current understanding of the prevalence and structure of 3-O-sulfation sites, expression and substrate specificity of the 3-O-sulfotransferase family and the emerging roles of 3-O-sulfation in biology.


Journal of Clinical Investigation | 2016

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Philip L.S.M. Gordts; Ryan Nock; Ni-Huiping Son; Bastian Ramms; Irene Lew; Jon C. Gonzales; Bryan E. Thacker; Debapriya Basu; Richard G. Lee; Adam E. Mullick; Mark J. Graham; Ira J. Goldberg; Rosanne M. Crooke; Joseph L. Witztum; Jeffrey D. Esko

Hypertriglyceridemia is an independent risk factor for cardiovascular disease, and plasma triglycerides (TGs) correlate strongly with plasma apolipoprotein C-III (ApoC-III) levels. Antisense oligonucleotides (ASOs) for ApoC-III reduce plasma TGs in primates and mice, but the underlying mechanism of action remains controversial. We determined that a murine-specific ApoC-III-targeting ASO reduces fasting TG levels through a mechanism that is dependent on low-density lipoprotein receptors (LDLRs) and LDLR-related protein 1 (LRP1). ApoC-III ASO treatment lowered plasma TGs in mice lacking lipoprotein lipase (LPL), hepatic heparan sulfate proteoglycan (HSPG) receptors, LDLR, or LRP1 and in animals with combined deletion of the genes encoding HSPG receptors and LDLRs or LRP1. However, the ApoC-III ASO did not lower TG levels in mice lacking both LDLR and LRP1. LDLR and LRP1 were also required for ApoC-III ASO-induced reduction of plasma TGs in mice fed a high-fat diet, in postprandial clearance studies, and when ApoC-III-rich or ApoC-III-depleted lipoproteins were injected into mice. ASO reduction of ApoC-III had no effect on VLDL secretion, heparin-induced TG reduction, or uptake of lipids into heart and skeletal muscle. Our data indicate that ApoC-III inhibits turnover of TG-rich lipoproteins primarily through a hepatic clearance mechanism mediated by the LDLR/LRP1 axis.


Journal of Biological Chemistry | 2011

Inhibitory Peptides of the Sulfotransferase Domain of the Heparan Sulfate Enzyme, N-Deacetylase-N-sulfotransferase-1

Tarsis F. Gesteira; Vivien Jane Coulson-Thomas; Alessandro Taunay-Rodrigues; Vitor Oliveira; Bryan E. Thacker; Maria A. Juliano; Renata Pasqualini; Wadih Arap; Ivarne L.S. Tersariol; Helena B. Nader; Jeffrey D. Esko; Maria Aparecida da Silva Pinhal

N-Deacetylase-N-sulfotransferase 1 (Ndst1) catalyzes the initial modification of heparan sulfate and heparin during their biosynthesis by removal of acetyl groups from subsets of N-acetylglucosamine units and subsequent sulfation of the resulting free amino groups. In this study, we used a phage display library to select peptides that interact with Ndst1, with the aim of finding inhibitors of the enzyme. The phage library consisted of cyclic random 10-mer peptides expressed in the phage capsid protein pIII. Selection was based on the ability of engineered phage to bind to recombinant murine Ndst1 (mNdst1) and displacement with heparin. Peptides that were enriched through multiple cycles of binding and disassociation displayed two specific sequences, CRGWRGEKIGNC and CNMQALSMPVTC. Both peptides inhibited mNdst1 activity in vitro, however, by distinct mechanisms. The peptide CRGWRGEKIGNC presents a chemokine-like repeat motif (BXX, where B represents a basic amino acid and X is a noncharged amino acid) and binds to heparan sulfate, thus blocking the binding of substrate to the enzyme. The peptide NMQALSMPVT inhibits mNdst1 activity by direct interaction with the enzyme near the active site. The discovery of inhibitory peptides in this way suggests a method for developing peptide inhibitors of heparan sulfate biosynthesis.


Journal of Orthopaedic Research | 2012

PASSIVE MECHANICAL PROPERTIES AND RELATED PROTEINS CHANGE WITH BOTULINUM NEUROTOXIN A INJECTION OF NORMAL SKELETAL MUSCLE

Bryan E. Thacker; Akihito Tomiya; Jonah B. Hulst; Kentaro P. Suzuki; Shannon N. Bremner; Randy F. Gastwirt; Marion L. Greaser; Richard L. Lieber; Samuel R. Ward

The effects of botulinum neurotoxin A on the passive mechanical properties of skeletal muscle have not been investigated, but may have significant impact in the treatment of neuromuscular disorders including spasticity. Single fiber and fiber bundle passive mechanical testing was performed on rat muscles treated with botulinum neurotoxin A. Myosin heavy chain and titin composition of single fibers was determined by gel electrophoresis. Muscle collagen content was determined using a hydroxyproline assay. Neurotoxin‐treated single fiber passive elastic modulus was reduced compared to control fibers (53.00 kPa vs. 63.43 kPa). Fiber stiffness and slack sarcomere length were also reduced compared to control fibers and myosin heavy chain composition shifted from faster to slower isoforms. Average titin molecular weight increased 1.77% after treatment. Fiber bundle passive elastic modulus increased following treatment (168.83  kPa vs. 75.14 kPa). Bundle stiffness also increased while collagen content per mass of muscle tissue increased 38%. Injection of botulinum neurotoxin A produces an effect on the passive mechanical properties of normal muscle that is opposite to the changes observed in spastic muscles.


Spine | 2010

Regional Myosin Heavy Chain Distribution in Selected Paraspinal Muscles

Gilad J. Regev; Choll W. Kim; Bryan E. Thacker; Akihito Tomiya; Steven R. Garfin; Samuel R. Ward; Richard L. Lieber

Study Design. Cross-sectional study with repeated measures design. Objective. To compare the myosin heavy-chain isoform distribution within and between paraspinal muscles and to test the theory that fiber-type gradients exist as a function of paraspinal muscle depth. Summary of Background Data. There is still uncertainty regarding the fiber-type distributions within different paraspinal muscles. It has been previously proposed that deep fibers of the multifidus muscle may contain a higher ratio of type I to type II fibers, because, unlike superficial fibers, they primarily stabilize the spine, and may therefore have relatively higher endurance. Using a minimally invasive surgical approach, using tubular retractors that are placed within anatomic intermuscular planes, it was feasible to obtain biopsies from the multifidus, longissimus, iliocostalis, and psoas muscles at specific predefined depths. Methods. Under an institutional review board-approved protocol, muscle biopsies were obtained from 15 patients who underwent minimally invasive spinal surgery, using the posterior paramedian (Wiltse) approach or the minimally invasive lateral approach. Myosin heavy chain (MyHC) isoform distribution was analyzed using SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) electrophoresis. Because multiple biopsies were obtained from each patient, MyHC distribution was compared using both within- and between-muscle repeated measures analyses. Results. The fiber-type distribution was similar among the posterior paraspinal muscles and was composed of relatively high percentage of type I (63%), compared to type IIA (19%) and type IIX (18%) fibers. In contrast, the psoas muscle was found to contain a lower percentage of type I fibers (42%) and a higher percentage of type IIA (33%) and IIX fibers (26%; P < 0.05). No significant difference was found for fiber-type distribution among 3 different depths of themultifidus and psoas muscles. Conclusion. Fiber-type distribution between the posterior paraspinal muscles is consistent and is composed of relatively high percentage of type I fibers, consistent with a postural function. The psoas muscle, on the other hand, is composed of a higher percentage of type II fibers such as in the appendicular muscles. Our data do not support the idea of a fiber-type gradient as a function of depth for any muscle studied.


Journal of Biomechanics | 2009

Passive mechanical properties of the lumbar multifidus muscle support its role as a stabilizer

Samuel R. Ward; Akihito Tomiya; Gilad J. Regev; Bryan E. Thacker; Robert C. Benzl; Choll W. Kim; Richard L. Lieber


ACS Chemical Biology | 2016

Expanding the 3-O-Sulfate Proteome - Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity

Bryan E. Thacker; Emylie Seamen; Roger Lawrence; Matthew W. Parker; Yongmei Xu; Jian Liu; Craig W. Vander Kooi; Jeffrey D. Esko


Molecular Genetics and Metabolism | 2018

Impaired mitophagy causes brown adipose tissue activation and cachexia in Sanfilippo syndrome type A mice

Jeffrey D. Esko; Chrissa A. Dwyer; Shih-hsin Kan; Norah Al-Azzam; Bryan E. Thacker; Charles A. Glass; Patricia Dickson; Raymond Y. Wang; Philip L.S.M. Gordts


Molecular Genetics and Metabolism | 2018

Guanidinylated neomycin conjugation enhances intranasal enzyme replacement in the brain

Jillian R. Brown; Wenyong Tong; Chrissa A. Dwyer; Bryan E. Thacker; Charles A. Glass; Kristina M. Hamill; Kelley W. Moremen; Stéphane Sarrazin; Philip L.S.M. Gordts; Gentry N. Patrick; Lara E. Dozier; Yitzhak Tor; Jonathan D. Cooper; Patricia Dickson; Jeffrey D. Esko

Collaboration


Dive into the Bryan E. Thacker's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akihito Tomiya

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roger Lawrence

University of California

View shared research outputs
Top Co-Authors

Avatar

Samuel R. Ward

University of California

View shared research outputs
Top Co-Authors

Avatar

Choll W. Kim

University of California

View shared research outputs
Top Co-Authors

Avatar

Emylie Seamen

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge